The Italy MedTech research landscape in 2026
The Italy medical devices market is estimated at EUR 12–14 billion in 2026, shaped by AIFA / EU MDR regulation, hospital procurement cycles, and Confindustria Dispositivi Medici members. Manufacturers launching or defending device portfolios need primary research that maps prescriber behaviour to committee and payer reality — not syndicated averages alone.
MedTech market research in Italy differs from pharmaceutical research: sample frames prioritise biomedical engineers, hospital value-analysis committees, and procedure specialists; evidence must address total cost of ownership, training burden, and maintenance contracts alongside clinical efficacy.
Global syndicated vendors provide audit data; specialist firms like BioNixus add verified hospital access, AIFA / EU MDR-aware study design, and decision-linked synthesis for launch sizing, competitive defence, and international expansion planning.
For company-intent programmes — not firm comparison — see our dedicated MedTech market research page for Italy. For broader healthcare context, start from the healthcare market research hub and /healthcare-market-research-italy.